Objectives: Trophoblast invasion and migration is an essential part of normal placentation and successful pregnancy. The process is well-controlled by many factors at the fetal-maternal surface. Inadequate trophoblast invasion may lead to poor placenta perfusion, or complications such as preeclampsia (PE). There is accumulating evidence that 
Introduction
Trophoblast cell invasion is a crucial progress for implantation, placentation and a successful pregnancy [1, 2] . In the early stage of placental development, cytotrophblast (CTB) cells rapidly proliferate and differentiate into syncytiotrophoblast (STB) and extravillious trophoblast (EVT), and EVTs then begin to invade into the surrounding maternal decidua, the capillary network and then arterioles and endometrial spiral arteries. The blood vessel walls are remodeled by this invasion at the maternal-fetal interface to provide sufficient nutrients and oxygen for the fetus [3, 4] . Impaired invasion of trophoblast cells into the maternal tissue or insufficient uterine spiral artery remodeling may lead to preeclampsia (PE) [2, 5] , intrauterine growth restriction [6] and other obstetric complications [7, 8] . The detailed molecular mechanism involved in regulating trophoblast invasion requires further elucidation.
There are several similarities between the behavior of placental cells and that of malignant tumor cells, such as invasion and growth characteristics [9] . However, the invasion of trophoblast is self-limited and is precisely regulated by the placenta-specific genes. This regulation ensures that invasion only occurs in early pregnancy and that it is restricted to the upper third of the myometrium [10, 11] . A number of factors are involved in this process [12] ; for example, CTBs secrete matrix metalloproteinases (MMPs) and its specific tissue inhibitor TIMPs. MMPs This is the authors' final accepted manuscript, post peer review. The version of record may be found at http://dx.doi.org/10.1016/j.placenta.2015.08. 014 and TIMPs remain in a dynamic balance and tightly control the invasion of EVTs into maternal endomyometrium [9, 13, 14] .
Changes in glycan are associated with altered cell behaviors, and can influence including adhesion, migration, growth, and differentiation [15, 16] . Glycosylation reactions are catalyzed by the glycosyltransferases, including N-acetylglucosaminyltransferase V (MGAT5), also known as GnT-V, which plays a regulatory role in the synthesis of complex N-glycans; this process is highly conserved in mammals [17, 18] . It has been reported that an aberrant glycosylation induced by MGAT5 is associated with tumor malignant transformation, including tumor invasion and metastasis. Enhanced activity of MGAT5, resulting in an increase of β1-6-branched oligosaccharides on the cell-surface, may contribute to the increased invasive potential of tumor cells [19] . Upregulated MGAT5 activity has been reported in human breast cancer, hepatocarcinoma and colon cancer [20] [21] [22] . Study of MGAT5 knockout mice showed decreased invasion and metastasis of the mammary tumors in vivo [23] , suggesting that inhibitors of MGAT5 may have potential in the treatment of tumors.
Furthermore, a higher expression of MGAT5 in first trimester placentas than those at term was determined [24] .
Although highly expressed in placenta, the role of MGAT5 in human trophoblast function has not been characterised. Our objective was to investigate our hypothesis that MGAT5 is involved in trophoblast This is the authors' final accepted manuscript, post peer review. The version of record may be found at http://dx.doi.org/10.1016/j.placenta.2015.08.014 migration and invasion. We also studied the effects of MGAT5 on MMP2/9 activity and expression of TIMP1/2. Tissue samples were transported to the laboratory immediately after surgery. For Western blotting, tissues were washed three times with ice-cold phosphate-buffered saline (PBS), stored in liquid-nitrogen jar-freezing and kept at -80°C until use. For immunohistochemistry, samples were washed with ice-cold PBS and fixed with 4% neutral paraformaldehyde, followed with gradient ethanol dehydration and embedding in paraffin. For explant culture, samples were cut into 1-5 mm 3 ,
Materials and Methods

Tissues collection
washed three times with ice-cold 0.9% saline and cultured immediately (see details in explant culture method).
Immunohistochemistry (IHC)
This is the authors' final accepted manuscript, post peer review. 
Immunofluorescence
HTR8/SVneo cells were subjected to indirect immunofluorescence staining as described previously [26] . The primary antibody used was the anti-MGAT5 antibody (1:100; NOVOUS). The secondary antibody used was a fluorescein isothiocyanate-conjugated goat anti-mouse antibody Serum-free Medium (100ul) without cells was used as a negative control.
The CCK8 assay was performed at the daily intervals from the first day to the third day after seeding, and optical density (OD) value was measured with a microplate reader (Bio-Rad, United States) at 450 nm. All assays were performed in triplicate and repeated three times.
Cell Apoptosis Assay
To quantify the rate of apoptosis in HTR8/SVneo cells pre-treated by shRNA, Annexin V-FITC and PI Apoptosis Detection Kits (Key-Gen Biotech, Nanjing, China) were used as previously described [27] . In brief, 
Villous explant cultures
Placental villous tissues (1-5mm 3 ) were dissected from the tips of villi and explanted as described previously [27, 29] . Serum-free DMEM/F12
(Gibco) medium with 500nM shRNA targeting MGAT5 or an equal concentration of the scrambled shRNA was added into wells and incubated under low oxygen tension (3% O2) for 72h before RNA and protein collection. The outgrowth and migration of EVT from the distal end of the villous tips were recorded daily for up to 3 days. The EVT migration distance (from the cell column base to the outgrowth tip) was measured by Image J software. The explant experiment was quadruplicated and repeated five times.
Gelatin zymography
The gelatinolytic activity was identified by gelatin zymographic analysis, as previously described [30, 31] . A total of 10ml protein from the 
Statistical analysis
Data are shown as the mean±SEM. All statistical analyses were performed using GraphPad Prism (GraphPad Software, San Diego, California). Differences between two groups were analyzed by independent t-test assuming a Gaussian distribution. A value of p < 0.05 was defined as statistically significant.
Results
MGAT5 was expressed in human first trimester placentas and extravillous trophoblast
To indentify the expression of MGAT5 in early placental tissue, the localization and distribution of MGAT5 was investigated in detailed by immunohistochemistry (Fig.1) . MGAT5 protein was specifically localized in villous CTB, syncytiotrophoblast (STB) and trophoblast columns (TC) (Fig. 1A and 1E ). In the maternal decidua, MGAT5 was expressed in the cells which were defined by human leukocyte antigen G (HLA-G) staining (Fig.1 D and 1H,) . Immunofluoresence staining confirmed that MGAT5
protein was presented and expressed in HTR8/SVneo cell line (Fig.2 A) . decreased apoptosis, we further identified the effect of MGAT5 on cell proliferation and apoptosis. The MGAT5 knockdown had no significant effects on cell proliferation (Fig.4A) or apoptosis (Fig.4B ) compared with the scrambled shRNA group. Taken together, in trophoblast, MGAT5
expression is negatively correlated with cell migration and invasion. 
Discussion
In the current study, we found that MGAT5 was expressed in the Numerous studies have been confirmed a upregulation of MAGT5 in human tumors, such as breast cancer [20] , colon carcinoma [22] and that upregulation of MGAT5 suggests favorable prognosis for bladder carcinoma [32] , non-small cell lung cancer [33] and neuroblastoma [34] . primary trophoblast cells, is that it both reflects the complicated relationship between different types of cells and maintains the integrity of the tissue structure [36] . Finally, upregulation of MMP2/9 and downregulation of TIMP1/2 were confirmed in the MGAT5 shRNA explants/cells.
Our data are inconsistent with previous studies in which knockdown of MGAT5 inhibited tumor cell invasion and migration [20] [21] [22] , but are in accord with studies which used the Jar human choriocarcinoma cell line. and that it is restricted to the proximal third of the myometrium [10, 35] .
The MMP family is considered to be key to tumor invasion, and high MMP9 expression is thought to be crucial for migration/invasion of endothelial cells into the adjacent stroma [13, 14] . MMPs, especially MMP2 and 9 play critical roles in trophoblast invasion by remodeling the ECM. The molecular mechanisms underlying the N-glycan regulation of the invasive function of MMP9 in placenta need to be elucidated. Here, we found that MGAT5 specific RNA interference in the explants and GnT-V in inducing migration of neck squamous cell carcinoma [40] . So, there may be another way of MGAT5 to regulate cell invasion and migration, our further study would focus on the underlying relationship between MGAT5 and α5β1 integrin.
Whether MGAT5 In summary, our present data demonstrated that MAGT5 is expressed in trophoblast cells in human first trimester placenta, and that MAGT5 restricted the migration and invasion of trophoblast cells by inhibiting the activities of MMP2/9. Therefore, MGAT5 may be an important regulator during placentation.
